SCHEMBL10671530

SCHEMBL10671530

CNc1c(C(=O)N(C)c2ccccc2)c(=O)n(C)c2ccc(OC)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ PGR P06401 1/20 0.55
▸ SRC P12931 2/20 0.47
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HIF1A Q16665 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ PADI4 Q9UM07 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HTR6 P50406 2/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR7 P34969 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10676615 0.86 MEN1 (0.71) MEN1KMT2APGRSRCKDM4E
SCHEMBL10677667 0.84 KMT2A (0.71) MEN1KMT2APGRSRCKDM4E
SCHEMBL9200433 0.83 MEN1 (0.55) MEN1KMT2APGRSRCKDM4E
SCHEMBL10679151 0.79 KMT2A (0.60) MEN1KMT2APGRSRCKDM4E
SCHEMBL10671773 0.79 MEN1 (0.54) MEN1KMT2APGRSRCHIF1A
SCHEMBL5163448 0.78 HDAC4 (0.59) MEN1KMT2APGRSRCALDH1A1
SCHEMBL9266139 0.77 MEN1 (0.54) MEN1KMT2APGRSRCKDM4E
SCHEMBL10672221 0.76 MEN1 (0.56) MEN1KMT2APGRKDM4EALDH1A1
SCHEMBL10674466 0.75 MEN1 (0.71) MEN1KMT2APGRSRCKDM4E
SCHEMBL10678936 0.75 MEN1 (0.78) MEN1KMT2APGRSRCKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4738971-A ENHANCED CELL-MEDIATED IMMUNITY; ANTIARTHRITIC AGENTS; NONTOXIC AKTIEBOLASET LEO (SE) 1988-04-19 — — US disclosed
US-4547511-A FOR ENHANCIN CELL-MEDIATED IMMUNITY AKTIEBOLAGET LEO (SE) 1985-10-15 — — US disclosed
EP-0059698-B1 HETEROCYCLIC CARBOXAMIDES, COMPOSITIONS CONTAINING SUCH COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND METHODS OF TREATMENT THEREWITH AB LEO (SE) 1985-09-25 — — EP disclosed
EP-0059698-A1 Heterocyclic carboxamides, compositions containing such compounds, processes for their preparation and methods of treatment therewith AB LEO (SE) 1982-09-08 — — EP disclosed
Send feedback